FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775638560> ?p ?o ?g. }

• W2775638560 endingPage "742" @default.
• W2775638560 startingPage "726" @default.
• W2775638560 abstract "// Dongjoon Ko 1, 2 and Semi Kim 1, 2, 3 1 Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Korea 2 Department of Functional Genomics, Korea University of Science and Technology, Daejon, Korea 3 Department of Chemistry, Korea Advanced Institute of Science and Technology, Daejon, Korea Correspondence to: Semi Kim, email: semikim@kribb.re.kr Keywords: ZEB2; cell survival; angiogenesis; Sp1; VEGF Received: June 07, 2017      Accepted: November 14, 2017      Published: December 11, 2017 ABSTRACT Epithelial-mesenchymal transition (EMT) is a process implicated in tumor invasion and metastasis. During EMT, epithelial cells undergo molecular changes to acquire mesenchymal phenotypes, which are mediated by EMT-inducing transcription factors. Previously, we showed that ZEB2 cooperates with the transcription factor Sp1 to function as a transcriptional activator of vimentin, integrin α5, and cadherin-11, which promotes cancer cell invasion. We hypothesized that ZEB2, through cooperation with Sp1, would mediate diverse cellular functions beyond EMT and invasion during metastasis. ZEB2 upregulated the expression of Sp1-regulated genes such as survivin, bcl-2, cyclin D1, and vascular endothelial growth factor in an Sp1-dependent manner, resulting in increased cancer cell survival and proliferation and endothelial cell activation in vitro , and increased circulating tumor cell survival and tumor angiogenesis in vivo. In addition, Sp1 enhanced ZEB2 stability, suggesting the presence of a positive feedback loop between ZEB2 and Sp1. Clinical data showed that ZEB2 expression was positively associated with Sp1 expression, and that the expression of both of these factors had prognostic significance for predicting survival in cancer patients. This study suggests that invasion is linked to cancer cell survival and angiogenesis by ZEB2 during cancer progression, and increases our understanding of the pathways via which EMT-inducing transcription factors regulate the complex process of metastasis." @default.
• W2775638560 created "2017-12-22" @default.
• W2775638560 creator A5020320673 @default.
• W2775638560 creator A5025478124 @default.
• W2775638560 date "2017-12-11" @default.
• W2775638560 modified "2023-10-18" @default.
• W2775638560 title "Cooperation between ZEB2 and Sp1 promotes cancer cell survival and angiogenesis during metastasis through induction of survivin and VEGF" @default.
• W2775638560 cites W1912392551 @default.
• W2775638560 cites W1964081206 @default.
• W2775638560 cites W1975357118 @default.
• W2775638560 cites W1978968302 @default.
• W2775638560 cites W1989012283 @default.
• W2775638560 cites W1990353372 @default.
• W2775638560 cites W1996118868 @default.
• W2775638560 cites W2004758839 @default.
• W2775638560 cites W2009663080 @default.
• W2775638560 cites W2016315295 @default.
• W2775638560 cites W2019214567 @default.
• W2775638560 cites W2019408938 @default.
• W2775638560 cites W2025647419 @default.
• W2775638560 cites W2029409898 @default.
• W2775638560 cites W2030537668 @default.
• W2775638560 cites W2039532716 @default.
• W2775638560 cites W2041140715 @default.
• W2775638560 cites W2059158933 @default.
• W2775638560 cites W2063011414 @default.
• W2775638560 cites W2074469807 @default.
• W2775638560 cites W2080232352 @default.
• W2775638560 cites W2094658364 @default.
• W2775638560 cites W2096798442 @default.
• W2775638560 cites W2097758673 @default.
• W2775638560 cites W2101317455 @default.
• W2775638560 cites W2102707911 @default.
• W2775638560 cites W2109998353 @default.
• W2775638560 cites W2111942409 @default.
• W2775638560 cites W2113860186 @default.
• W2775638560 cites W2114843025 @default.
• W2775638560 cites W2114906733 @default.
• W2775638560 cites W2135205703 @default.
• W2775638560 cites W2140551998 @default.
• W2775638560 cites W2141522277 @default.
• W2775638560 cites W2149441684 @default.
• W2775638560 cites W2153954746 @default.
• W2775638560 cites W2170241782 @default.
• W2775638560 cites W2262414037 @default.
• W2775638560 cites W2281279142 @default.
• W2775638560 cites W2396652017 @default.
• W2775638560 cites W2411857930 @default.
• W2775638560 cites W2463600666 @default.
• W2775638560 cites W2467235925 @default.
• W2775638560 cites W2737785069 @default.
• W2775638560 doi "https://doi.org/10.18632/oncotarget.23139" @default.
• W2775638560 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5787504" @default.
• W2775638560 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29416649" @default.
• W2775638560 hasPublicationYear "2017" @default.
• W2775638560 type Work @default.
• W2775638560 sameAs 2775638560 @default.
• W2775638560 citedByCount "15" @default.
• W2775638560 countsByYear W27756385602019 @default.
• W2775638560 countsByYear W27756385602020 @default.
• W2775638560 countsByYear W27756385602021 @default.
• W2775638560 countsByYear W27756385602023 @default.
• W2775638560 crossrefType "journal-article" @default.
• W2775638560 hasAuthorship W2775638560A5020320673 @default.
• W2775638560 hasAuthorship W2775638560A5025478124 @default.
• W2775638560 hasBestOaLocation W27756385601 @default.
• W2775638560 hasConcept C121608353 @default.
• W2775638560 hasConcept C137738243 @default.
• W2775638560 hasConcept C147447768 @default.
• W2775638560 hasConcept C1491633281 @default.
• W2775638560 hasConcept C199835354 @default.
• W2775638560 hasConcept C203014093 @default.
• W2775638560 hasConcept C204232928 @default.
• W2775638560 hasConcept C2775975398 @default.
• W2775638560 hasConcept C2779013556 @default.
• W2775638560 hasConcept C2780394083 @default.
• W2775638560 hasConcept C29537977 @default.
• W2775638560 hasConcept C502942594 @default.
• W2775638560 hasConcept C54355233 @default.
• W2775638560 hasConcept C71924100 @default.
• W2775638560 hasConcept C76419328 @default.
• W2775638560 hasConcept C86803240 @default.
• W2775638560 hasConceptScore W2775638560C121608353 @default.
• W2775638560 hasConceptScore W2775638560C137738243 @default.
• W2775638560 hasConceptScore W2775638560C147447768 @default.
• W2775638560 hasConceptScore W2775638560C1491633281 @default.
• W2775638560 hasConceptScore W2775638560C199835354 @default.
• W2775638560 hasConceptScore W2775638560C203014093 @default.
• W2775638560 hasConceptScore W2775638560C204232928 @default.
• W2775638560 hasConceptScore W2775638560C2775975398 @default.
• W2775638560 hasConceptScore W2775638560C2779013556 @default.
• W2775638560 hasConceptScore W2775638560C2780394083 @default.
• W2775638560 hasConceptScore W2775638560C29537977 @default.
• W2775638560 hasConceptScore W2775638560C502942594 @default.
• W2775638560 hasConceptScore W2775638560C54355233 @default.
• W2775638560 hasConceptScore W2775638560C71924100 @default.
• W2775638560 hasConceptScore W2775638560C76419328 @default.
• W2775638560 hasConceptScore W2775638560C86803240 @default.

• next